- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
Results
8552
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,552 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
SKS | AU$2.21 | 2.3% | 750.0% | AU$247.7m | AU$2.15 | PE37.4x | E24.8% | 0.5% | Capital Goods | ||
9958 | NT$160.50 | 6.3% | -25.9% | NT$41.2b | NT$238.00 | PE19.6x | E44.9% | 1.9% | Materials | ||
MBTN | CHF 1.92 | -16.1% | -98.0% | CHF 70.0m | CHF 6.03 | PS0.7x | E109.3% | n/a | Semiconductors | ||
CADLR | NOK 57.40 | -4.5% | 22.1% | NOK 20.2b | NOK 82.10 | PE188.1x | E70.9% | n/a | Capital Goods | ||
PHM | €79.35 | 3.1% | 89.4% | €1.4b | €84.40 | PE2220.6x | E55.1% | 0.8% | Pharmaceuticals & Biotech | ||
RHM | €717.80 | 9.4% | 116.4% | €30.6b | €725.20 | PE45.5x | E29.9% | 0.8% | Capital Goods | ||
ELABS | NOK 11.40 | 8.4% | -30.7% | NOK 1.1b | NOK 19.00 | PS12.8x | E121.1% | n/a | Software | ||
GUINNESS | ₦70.00 | 0% | -1.1% | ₦153.3b | ₦74.24 | PS0.4x | E116.7% | 0% | Food, Beverage & Tobacco | ||
FWRY | ج.م8.52 | 1.7% | 56.6% | ج.م28.8b | ج.م12.45 | PE23.5x | E27.4% | n/a | Diversified Financials | ||
WAYS | SEK 15.40 | 0.3% | -45.3% | SEK 131.9m | SEK 36.50 | PS1x | E113.3% | 0% | Tech | ||
MVW | NOK 8.80 | -2.8% | 1.9% | NOK 286.3m | NOK 11.70 | PS15x | E71.7% | n/a | Materials | ||
NEWBRY | SEK 3.54 | 2.3% | -24.7% | SEK 85.4m | SEK 8.00 | PS2.3x | E130.0% | n/a | Pharmaceuticals & Biotech | ||
RMDA | ج.م3.44 | 6.2% | 83.5% | ج.م5.0b | ج.م5.02 | PE19.4x | E30.7% | 2.0% | Pharmaceuticals & Biotech | ||
AFISH | NOK 67.00 | -3.6% | 12.6% | NOK 2.2b | NOK 83.50 | PE65.2x | E66.5% | n/a | Food, Beverage & Tobacco | ||
INIT | SEK 6.80 | -4.2% | -20.9% | SEK 392.9m | SEK 22.50 | PB15.8x | E31.7% | n/a | Pharmaceuticals & Biotech | ||
ACE | SEK 3.08 | -1.8% | -61.5% | SEK 303.2m | SEK 8.25 | PB2.8x | E47.2% | n/a | Pharmaceuticals & Biotech | ||
ICOP | €7.84 | -5.5% | n/a | €222.2m | €9.80 | PE42.9x | E49.2% | n/a | Capital Goods | ||
PRL | CA$36.94 | 5.6% | 115.3% | CA$1.4b | CA$45.92 | PE22.9x | E38.9% | 1.6% | Diversified Financials | ||
ZVRA | US$8.15 | 1.7% | 42.0% | US$435.0m | US$20.63 | PS17.8x | E57.8% | n/a | Pharmaceuticals & Biotech | ||
ONON | US$58.56 | 7.0% | 124.8% | US$19.2b | US$61.56 | PE134.9x | E29.8% | n/a | Consumer Durables | ||
ALKT | US$35.30 | 1.6% | 46.2% | US$3.6b | US$45.10 | PS11.2x | E102.7% | n/a | Software | ||
RCEL | US$8.48 | -4.9% | -46.4% | US$230.8m | US$17.08 | PS3.7x | E51.9% | n/a | Pharmaceuticals & Biotech | ||
ARES | US$193.81 | 5.0% | 65.0% | US$61.0b | US$189.62 | PE90.5x | E38.4% | 1.9% | Diversified Financials | ||
GAU | CA$1.65 | 0% | 39.8% | CA$416.5m | CA$3.47 | PS1.8x | E107.8% | n/a | Materials |